Finance

Lists
Why is OCUL up 5.11%?
Dive Deeper
OCUL:NASDAQ
Ocular Therapeutix Inc
$10.50
+5.11%
(+0.51) 1D
$10.45
-0.48% (-0.050)
After hours
Closed: Sep 22, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OCUL...
Open
$10.08
High
$10.61
Low
$10.02
Mkt. cap
2.31B
Avg. vol.
2.68M
Volume
2.50M
52-wk high
$16.44
52-wk low
$6.23
EPS
-$1.41
Beta
0.97
Shares outstanding
219.62M
No. of employees
325
Open
$10.08
High
$10.61
Low
$10.02
Mkt. cap
2.31B
Avg. vol.
2.68M
Volume
2.50M
52-wk high
$16.44
52-wk low
$6.23
EPS
-$1.41
Beta
0.97
Shares outstanding
219.62M
No. of employees
325
News stories
From web sources and news partners
About Ocular Therapeutix Inc
CEOPravin Dugel
Employees325
Founded2006
HeadquartersBedford, Massachusetts, United States
SectorPharmaceutical industry
Websiteocutx.com
Analyst ratings
Based on 9 analysts giving stock ratings to OCUL in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for OCUL in the last 3 months.
Highest
Current $10.50
$31.00 (+195.24%)
Average
$25.25 (+140.48%)
Lowest
$18.00 (+71.43%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Reiterated
$25.00
+138.1%
09/16/2026
Tazeen Ahmad
Bank of America Securities
Buy
Maintained
$27.00
+157.1%
09/15/2026
Lachlan Hanbury Brown
William Blair
Buy
Maintained
-
-
09/15/2026
Biren Amin
Piper Sandler
Buy
Maintained
$31.00
+195.2%
08/26/2026
William Maughan
Clear Street
Buy
Reiterated
$28.00
+166.7%
08/18/2026
Serge Belanger
Needham
Buy
Maintained
$18.00
+71.4%
08/17/2026
Tara Bancroft
TD Cowen
Buy
Maintained
$20.00
+90.5%
08/03/2026
Lisa Walter
RBC Capital
Buy
Maintained
$30.00
+185.7%
08/03/2026
Daniil Gataulin
Chardan Capital
Buy
Maintained
$23.00
+119%
06/25/2026
Colleen M. Kusy
Robert W. Baird
Buy
Maintained
$30.00
+185.7%
06/18/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
-
-
02/17/2026
Clara Dong
Jefferies
Buy
Maintained
$28.00
+166.7%
02/17/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
14.54M
13.25M
10.78M
13.48M
Cost of goods sold
54.13M
52.39M
67.54M
56.15M
Cost of revenue
54.13M
52.39M
67.54M
56.15M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
29.11M
30.62M
36.58M
39.44M
Operating expense
29.11M
30.62M
36.58M
39.44M
Total operating expenses
83.24M
83.01M
104.12M
95.58M
Operating income
-68.70M
-69.76M
-93.34M
-82.11M
Other non operating income
-1.45M
624.00K
1.46M
689.00K
EBT including unusual items
-69.42M
-64.65M
-88.61M
-78.76M
EBT excluding unusual items
-69.42M
-64.62M
-88.61M
-78.76M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-69.42M
-64.65M
-88.61M
-78.76M
Net profit margin
-477.30%
-487.95%
-821.62%
-584.51%
Earnings per share
-0.38
-0.29
-0.40
-0.35
Interest and investment income
3.73M
7.34M
6.05M
5.45M
Interest expense
-3.00M
-2.83M
-2.78M
-2.79M
Net interest expenses
727.00K
4.51M
3.27M
2.66M
Depreciation and amortization charges
-
-
-
-
EBITDA
-67.63M
-68.51M
-92.06M
-80.26M
Gain or loss from assets sale
-
-
4.87M
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps